Matthias Ocker
- Toxicology top 0.2%
- Molecular Biology top 2%
- Histone Deacetylase Inhibitors Research 32
- Epigenetics and DNA Methylation 17
- Protein Degradation and Inhibitors 14
- Fibroblast Growth Factor Research 12
- Cancer Research top 5%
- Oncology top 2%
-
- Liver Disease Diagnosis and Treatment 21
-
- Cancer Mechanisms and Therapy 16
-
- Liver physiology and pathology 10
-
- Endoplasmic Reticulum Stress and Disease 10
- Co-authors
- Regine Schneider‐StockDaniel NeureiterHala Gali‐MuhtasibPietro Di FazioC. HeroldMarion GanslmayerAmr AminKarl Quint
- Journals
- Cancer Research (13 papers)International Journal of Oncology (7 papers)Journal of Hepatology (5 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Matthias Ocker
160 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 123
- Toxicology 374
- Complementary and alternative medicine 464
- Molecular Biology 2.9k
- Cancer Research 626
- Oncology 1.1k
Countries citing papers authored by Matthias Ocker
This map shows the geographic impact of Matthias Ocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ocker more than expected).
Fields of papers citing papers by Matthias Ocker
This network shows the impact of papers produced by Matthias Ocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ocker. The network helps show where Matthias Ocker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Ocker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 45 | |
| 4 | 2022 | 14 | |
| 5 | 2021 | 6 | |
| 6 | 2018 | 25 | |
| 7 | 2017 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2014 | 41 | |
| 10 | 2013 | 4 | |
| 11 | 2012 | 104 | |
| 12 | 2012 | 13 | |
| 13 | 2011 | 98 | |
| 14 | 2010 | 58 | |
| 15 | 2010 | 54 | |
| 16 | 2009 | 21 | |
| 17 | 2008 | 129 | |
| 18 | 2008 | 4 | |
| 19 | 2007 | 136 | |
| 20 | 2003 | 33 |
About Matthias Ocker
Matthias Ocker is a scholar working on Hepatology, Oncology, Cancer Research, Toxicology and Pathology and Forensic Medicine, having authored 161 papers that have together received 5.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (32 papers), Liver Disease Diagnosis and Treatment (21 papers), Epigenetics and DNA Methylation (17 papers), Cancer Mechanisms and Therapy (16 papers), Protein Degradation and Inhibitors (14 papers), Fibroblast Growth Factor Research (12 papers), Liver physiology and pathology (10 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). The work is most often cited by research in Toxicology (374 citations), Complementary and alternative medicine (464 citations), Molecular Biology (2.9k citations), Cancer Research (626 citations) and Oncology (1.1k citations). Matthias Ocker has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Regine Schneider‐Stock, Daniel Neureiter, Hala Gali‐Muhtasib, Pietro Di Fazio, C. Herold, Marion Ganslmayer, Amr Amin, Karl Quint, Detlef Schuppan and Eckhart G. Hahn. Their work appears in journals such as Cancer Research, International Journal of Oncology, Journal of Hepatology, Expert Opinion on Investigational Drugs and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.